Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-24 @ 3:31 PM
NCT ID:
NCT01609192
Eligibility Criteria:
Inclusion Criteria:
* Men from 18 to 60 years old
* Patients diagnosed with sickle-cell anemia homozygote or S beta thal
* Patients for whom a treatment by hydroxyurea is prescribed for the first time.
* Patients having signed the informed consent
* Patients with social security
Exclusion Criteria:
* Patients already subjected to a treatment potentially sterilizing
* Patients under supervision or guardianship
* Patients that must begin or stop(arrest) a transfusional program between the beginning of the hydroxyurea and the spermogram in 6 months of treatment.
* Rate of ferritin \> 2500 µg/l
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01609192
Study Brief:
Protocol Section:
NCT01609192